Report Overview: The Global AI in Drug Discovery Market achieved a valuation of $1.3 Billion in 2022 and is anticipated to exceed $7.1 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 23.72% during the forecast period from 2024 to 2032. Key Market Players: IBM Corporation (US), Microsoft (US), and Google (US), NVIDIA Corporation (US), Atomwise, Inc. (US),...